openPR Logo
Press release

Volpara and Yellowfin Unveil Cloud Analytics Product for Breast Cancer Screening

06-03-2016 04:37 PM CET | Health & Medicine

Press release from: Yellowfin

Australian and New Zealand combined innovation leading the world in cloud-based analytics for breast cancer screening and diagnosis.

Melbourne, Victoria, Australia, June 02, 2016 -- Melbourne-based global Business Intelligence (BI) and analytics software vendor, Yellowfin, has announced that its platform has been integrated into Volpara Solutions’ world-first cloud-based analytics product, VolparaEnterprise, due to launch in 2016.

VolparaEnterprise will deliver the best possible data-driven insights to a range of user types – from clinicians to business managers and scientists – to assist with early and more effective breast cancer screening and diagnosis.

For further information, download the Yellowfin – Volpara case study here: yellowfinbi.com/Document.i4?DocumentId=851076

View a filmed Q&A with Volpara’s Technical Sales Manager, Paul Clancy, here: https://www.youtube.com/watch?v=htkAaE-PkAU

View a Sky News Business interview with Volpara Solutions CEO, Ralph Highnam Ph.D here: https://youtu.be/Nw9iZCk_ADw

Volpara Solutions’ parent company, Volpara Health Technologies, is a global healthcare software developer headquartered in Wellington, New Zealand. Volpara’s breast imaging products are used in over 30 countries.

“Yellowfin has allowed Volpara to take a proof-of-concept design and make it into a fully-fledged, completely rebranded cloud-ready product – all in the space of months, not years,” said Volpara Technical Sales Manager, Paul Clancy. “It has enabled us to deliver a world-first product to our global network of customers, including non-English speaking markets such as Japan.”

Volpara’s existing suite of quantitative breast imaging products provide accurate estimates of breast density – an important factor in determining a women’s suitability for mammography and her lifetime cancer risk. Volpara recognised its existing products were producing a significant volume of valuable and actionable clinical data, and that a cloud-based analytics platform would pave the way for clients to start visualising Big Data analytics to gain unprecedented insights.

“The VolparaEnterprise analytics solution, powered by Yellowfin’s BI platform and hosted in Microsoft’s Azure cloud, will offer users a complete overview of a breast imaging clinic – from the patients with whom they consult, to the quality of mammograms taken and how their machines and operators are performing,” said Yellowfin co-Founder and CEO, Glen Rabie.

According to Clancy, integrating Yellowfin into its VolparaEnterprise analytics product has empowered Volpara to deliver a world-first cloud-based service. Additionally, the scalability and flexibility of the cloud-based platform has enabled Volpara to expand its global reach and open up new opportunities within current markets.

“Yellowfin allows us to easily design the right reports, charts and dashboards for each kind of user,” said Clancy. “Business users can easily see high-level statistics, while scientists and deep-data lovers can quickly analyse detailed data, drilling all the way down to the level they desire.”

Volpara also cited easy configuration and simple integration with its SQL database, as well as the ability to translate both system information and content in Yellowfin, as technical reasons underpinning the partnership decision. Volpara Solutions’ parent company, Volpara Health Technologies (ASX: VHT), listed on the Australian Securities Exchange on 27 April this year.

About Yellowfin:
Yellowfin is a global Business Intelligence (BI) and analytics software vendor passionate about making BI easy. Founded in 2003 in response to the complexity and costs associated with implementing and using traditional BI tools, Yellowfin is a highly intuitive 100 percent Web-based reporting and analytics solution. Yellowfin is a leader in mobile, collaborative and embedded BI, as well as Location Intelligence and data visualization. Over 10,000 organizations, and more than 2 million end-users across 70 different countries, use Yellowfin every day. For more information, visit www.yellowfinbi.com. For regular news and updates, follow Yellowfin on Twitter (@YellowfinBI), LinkedIn (Yellowfin Business Intelligence), YouTube (Yellowfin Team) or email pr@yellowfin.bi to subscribe to Yellowfin’s free e-newsletter.

For further media information, interviews, images or product demonstration, please contact:
Lachlan James, Yellowfin Global Communications Manager on +61 (0)3 8617 4954, +61 (0)431 835 658 or lachlan.james@yellowfin.bi

Yellowfin is a global Business Intelligence (BI) and analytics software vendor passionate about making BI easy.

Contact:
Lachlan James
Yellowfin
Level 46, 360 Elizabeth Street
Melbourne 3000, Victoria
+61 0 3 8617 4954
lachlan.james@yellowfin.bi
http://www.yellowfinbi.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Volpara and Yellowfin Unveil Cloud Analytics Product for Breast Cancer Screening here

News-ID: 343186 • Views:

More Releases for Volpara

Breast Ultrasound Market Will Hit Big Revenues In Future | Volpara Health, BK Me …
HTF MI recently introduced Global Breast Ultrasound Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2024-2032). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence. Some key players from the complete study are GE Healthcare, Siemens Healthineers, Philips Healthcare, Hologic, Fujifilm, SonoCine, Canon Medical, Samsung Medison,
AI-Enabled Medical Imaging Solutions Market 2022 SWOT Analysis and Significant G …
Market Research, Inc. published a report titled "AI-Enabled Medical Imaging Solutions Market" research report which covers inclusive data on established trends, drivers, growth opportunities and restraints that can change the market dynamics of the global industry. This report provides an in-depth analysis of the market segmentation that includes products, applications and geographical analysis. It also includes market drivers and restraints of the market, which are derived from SWOT analysis.
Lung cancer screening software Market to Witness High Growth in Near Future | Me …
DBMR has added a new report titled Lung Cancer Screening Software Market with analysis provides the insights which bring marketplace clearly into the focus and thus help organizations make better decisions. With a devotion and commitment of supreme level of resilience and integrated approaches, Lung Cancer Screening Software Market research report has been structured. The report also puts a light on growth opportunity assessment (GOA), customer insights (CI), competitive business
Global Lung Cancer Screening Software Market 2020-2028 with Penrad, Eon, Philips …
Doctor recommend screening test for lung cancer is low-dose computed tomography (also called a low-dose CT scan, or LDCT). During an LDCT scan, an X-ray machine uses a low dose (amount) of radiation to make a detailed visualization of your lungs. The scan only takes a few minutes and is not painful. A new report on Global Lung Cancer Screening Software Market has been added in Report Consultant. The report gives
CAGR 19.63% of Lung Cancer Screening Software Market Analysis by Eon, Koninklijk …
This Global Lung Cancer Screening Software Market analysis report also offers list of the chief competitors and provides the strategic insights and analysis of the key factors influencing the industry. All statistical and numerical data is interpreted with the use of established and advanced tools such as SWOT analysis and Porter's Five Forces Analysis. This Lung Cancer Screening Software business document is built with the careful efforts of innovative, enthusiastic,
Lung Cancer Screening Software Market – Lead by Koninklijke Philips N.V.; Khei …
This Lung Cancer Screening Software report reveals detailed information about the global key players as well as some small players of the market. the information of each competitor includes company profiles, SWOT analysis, sales and revenue. This Lung Cancer Screening Software report studies the market status and outlook of global market and splits the market by product type and application. The overall effect on the consumer preferences will have